64 results on '"Schmidt, Warren N"'
Search Results
2. Zinc Protoporphyrin Binding to Telomerase Complexes and Inhibition of Telomerase Activity
3. Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships
4. Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo
5. HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes
6. Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders
7. Su1501 Assessment of Gastric Mucosal Injury in Patients With Cirrhosis
8. Antibodies to Chromosomal Non-Histone Proteins in Malignant Cells
9. Direct-Acting Antiviral Agents and the Path to Interferon Independence
10. Restoration of Type I Interferon Expression by Heme and Related Tetrapyrroles Through Inhibition of NS3/4A Protease
11. Heme and HO-1 Inhibition of HCV, HBV, and HIV
12. Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture
13. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans
14. Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?
15. Portosystemic Encephalopathy Due to Mesoiliac Shunt in a Patient Without Cirrhosis
16. Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells
17. Increased plasma nitric oxide, L‐arginine, and arginase‐1 in cirrhotic patients with progressive renal dysfunction
18. 831 FibroTest (Ft) Baseline Value Is An Independent Predictor of Early (EVR) and Sustained Virological Response (SVR) in Non-Responders Patients Re-Treated with Pegylated Interferon Alfa-2B (PEG-2B) and Ribavirin in EPIC3
19. Reply
20. Altered expression of iron regulatory genes in cirrhotic human livers: clues to the cause of hemosiderosis?
21. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury
22. S1001 Clearance of HCV At 5 Year Follow-Up for Peginterferon Alfa-2b ± Ribavirin Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment
23. W1710 Decreased Expression of Peripheral IL-10 mRNA and Deregulation of Immunoregulatory Function in Patients with Decompensated Cirrhosis
24. S1000 Results from the Epic3 Program: Platelet Counts Are Strong Predictors of Sustained Viral Response (SVR) in the RE-Treatment of Previous Interferon/Ribavirin Non-Responders (Nr)
25. Hepatitis C core protein inhibits induction of heme oxygenase-1 and sensitizes hepatocytes to cytotoxicity
26. Older Donor Livers Show Early Severe Histological Activity, Fibrosis, and Graft Failure After Liver Transplantation for Hepatitis C
27. Increased hepatic telomerase activity in a rat model of iron overload: A role for altered thiol redox state?
28. Treatment of hepatitis C cryoglobulinemia: Mission and challenges
29. Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection
30. Positive Serum Cryoglobulin Is Associated with Worse Outcome after Liver Transplantation for Chronic Hepatitis C
31. Hepatitis C virus‐core and non structural proteins lead to different effects on cellular antioxidant defenses
32. Expression of HSP47, a collagen-specific chaperone, in normal and diseased human liver
33. GB Virus Type C NS5A Sequence Polymorphisms: Association with Interferon Susceptibility and Inhibition of PKR-Mediated eIF2α Phosphorylation
34. Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis
35. Down‐Regulation of Heme Oxygenase–1 by Hepatitis C Virus Infection In Vivo and by the In Vitro Expression of Hepatitis C Core Protein
36. Seronegative Hepatitis C Virus Infection, Not Just RNA Detection
37. Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co‐expressing HCV core protein and CYP2E1
38. HCV core protein promotes increased oxidative stress and glutathione depletion in HepG2 cells that overexpress P450 microsomal enzyme CYP2E1
39. Risk factors for the development of progressive renal dysfunction in post-liver transplant recipients
40. Recombinant hepatitis C virus-like particles expressed by baculovirus: Utility in cell-binding and antibody detection assays
41. Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis
42. Hepatitis C Virus Viremia in HIV-Infected Individuals With Negative HCV Antibody Tests
43. Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor
44. Rebetron® therapy of chronic hepatitis C patients who were non-responsive to or relapsed on interferon monotherapy-predicting relapse
45. Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology
46. Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis C Virus RNA Detection Systems: Improved Detection Using Whole Blood as the Source of Viral RNA
47. Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells
48. Characterization of Hepatitis G Virus (GB-C Virus) Particles: Evidence for a Nucleocapsid and Expression of Sequences Upstream of the E1 Protein
49. Distribution of Hepatitis C Virus (HCV) RNA in Whole Blood and Blood Cell Fractions: Plasma HCV RNA Analysis Underestimates Circulating Virus Load
50. Surreptitious Hepatitis C Virus (HCV) Infection Detected in the Majority of Patients with Cryptogenic Chronic Hepatitis and Negative HCV Antibody Tests
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.